Clinical trial
Green Tea Extract in Treating Patients With Actinic Keratosis
NCT00005097 · Frank Meyskens, Other · Terminated
Key facts
| NCT number | NCT00005097 |
|---|---|
| Title | Green Tea Extract in Treating Patients With Actinic Keratosis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Polyphenon E Against Various Endpoints of Actinic Keratosis Pathobiology |
| Lead sponsor | Frank Meyskens, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | Polyphenon E and Placebo |
| Enrollment | 88 |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Apr 2, 2004 |
| Last update posted | Apr 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: